Hypertension-related stroke risk can be decreased by lowering systolic BP to less than 140 mm Hg via aggressive pharmacological treatment.

Sexual and gender-minority (SGM) persons have increased odds of adverse brain health outcomes, according to a study.

Oral cladribine over a 2-year treatment period promotes remyelination in patients with highly active relapsing-remitting multiple sclerosis.

Reducing or preventing paramagnetic rim lesions (PRLs) could significantly slow multiple sclerosis (MS) progression.

Age at menarche and duration of breastfeeding were both positively correlated with hand grip strength among older female individuals.

Delayed vs timely antiviral treatment initiation in adults hospitalized with influenza-associated pneumonia is linked to higher mortality risk.

Emotion-based climate anxiety predicts significant increases in cognitive-emotional impairment and generalized anxiety over time.

Black and Hispanic patients with preeclampsia are less likely to receive postpartum primary care or cardiology follow-up within 1 year after delivery.

Regional anesthesia may reduce chronic postsurgical pain up to 6 months and mitigate risk for persistent opioid use after elective noncardiac surgery.

Ubrogepant use during the migraine prodrome is tied to better ability to function normally and reduced activity limitations.

Mild depressive symptoms in the preclinical stages of Alzheimer disease may be predictive of greater longitudinal amyloid burden.

Migraine disability is associated with high levels of symptom severity, allodynia, and substantial burden in Canada, France, Germany, Japan, UK, and US.